Objectives: To examine age, racial, and regional differences in serum PSA levels among men in Louisiana.

Methods: From January 1, 2001 through December 31, 2001, there were 10,012 serum PSA tests performed at Louisiana Health Care Services Division (HCSD) hospitals. Manual and electronic data mining were performed to select the earliest PSA value in those men who had multiple determinations. This PSA data file was then linked with those of the Louisiana Tumor Registry and from HCSD pathology laboratories, all matched cases were removed. Men younger than 40 years and older than 79 years were excluded from this study. The final data file contained 7,258 men, of whom 4,244 were African-Americans and 3,014 were Caucasians. Comparisons of median and geometric mean serum PSA level were made between and among races for each age-decade as well as among the hospitals to assess for racial and regional differences.

Results: Median PSA levels were statistically significantly higher in African-American men than in Caucasian men for each age group (p < or = 0.0002). The median PSA (ng/ml) for African-American men was 0.7, 0.9, 1.3, and 2.3 for age-decades 40-49, 50-59, 60-69, and 70-79, respectively, whereas for Caucasian men the median PSA levels were 0.8, 1.2, and 1.6 for age-decades 50-59, 60-69, and 70-79, respectively. Nonparametric analysis of variance did not demonstrate a regional pattern of PSA values among the hospitals.

Conclusions: In a first statewide analysis of age and racial differences of serum PSA levels, African-American men without prostate cancer had significantly higher serum PSA levels than their age-matched Caucasian male counterparts. Additionally, there were no regional patterns of PSA values among the racial groups.

Download full-text PDF

Source

Publication Analysis

Top Keywords

serum psa
20
psa levels
20
psa
12
median psa
12
african-american men
12
men
10
statewide analysis
8
men prostate
8
prostate cancer
8
age racial
8

Similar Publications

This study introduces the development of a highly sensitive label-free electrochemical immunosensor specifically designed to detect prostate-specific antigen (PSA). A glassy carbon electrode (GCE) coated with Au nanoparticles/polyhedral hollow CoCu bimetallic sulfide (CuCoS) was employed as a sensing interface for the fixation of the monoclonal anti-PSA antibody. The nanoarchitectures enhanced the capacity for loading prostate-specific antibodies (Ab) and effectually boosted electrical conductivity leading to enhance the electrochemical signal and greater sensitivity for the detection of PSA.

View Article and Find Full Text PDF

Objective: To evaluate the outcomes and efficacy of robot-assisted radical prostatectomy (RARP) using the Versius robotic surgical system, aiming to provide comprehensive data on perioperative outcomes, postoperative recovery, and complications.

Patient And Methods: All cases of RARP using the CMR Versius platform performed at Cairo University Hospital over a two-year period were enrolled in this study. All patients had pathologically confirmed prostate cancer in both localized and locally advanced stages.

View Article and Find Full Text PDF

Specific immunohistochemical expression of Mmp-26 in prostatic adenocarcinoma.

An Acad Bras Cienc

January 2025

Universidade Federal de Pernambuco, Departamento de Histologia e Embriologia, Av. Prof. Moraes Rego, 1235, Cidade Universitária, 50760-420 Recife, PE, Brazil.

Matrix metalloproteinases (MMP) have been identified as biomarkers for several diseases, including cancer. The increase in the expression of these enzymes has been related to greater tumor aggressiveness. MMP-26 is expressed constitutively in the endometrium and some cancer cells of epithelial origin.

View Article and Find Full Text PDF

Purpose: After failing primary and secondary hormonal therapy, castration-resistant and neuroendocrine prostate cancer metastatic to the bone is invariably lethal, although treatment with docetaxel and carboplatin can modestly improve survival. Therefore, agents targeting biologically relevant pathways in PCa and potentially synergizing with docetaxel and carboplatin in inhibiting bone metastasis growth are urgently needed.

Experimental Design: Phosphorylated (activated) AXL expression in human prostate cancer bone metastases was assessed by immunohistochemical staining.

View Article and Find Full Text PDF

Background: Bone marrow (BM) in addition to being the origin of primary hematological malignancies is also commonly involved in metastatic solid tumors. Bone marrow examination includes aspiration and biopsy, and it is a well-known procedure not only to diagnose hematological malignancies but also for staging and prognosis of various solid tumors. The presence of metastasis in the bone marrow is of grave prognostic significance and it is imperative to rule out marrow involvement in any malignancy where curative treatment is considered.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!